1. HBW Insight
  2. >>Wellness
  3. >>Business
  4. >>Deals

Sanofi Starting US Cialis OTC Actual Use Study Soon While Tamiflu Switch Progress Delayed

French Pharma Reports €1.33Bn Q1 Consumer Health Sales Helped By Price Increases

 
• By Malcolm Spicer

After 118.2% cough/cold sales growth leads 17% overall consumer business growth, Sanofi points to still stronger days ahead while keeping the business under the same roof with its pharmaceutical and vaccine divisions.

• Source: Sanofi

Sanofi reports an historic step for the potential first US OTC switch of an erectile dysfunction drug while refusing even the slightest nod toward an imminent spin-out of its consumer business, a key driver in its 8.6% net sales growth for its latest quarter.

After cough/cold sales led the way in the first quarter at 118.2% growth for 17% overall consumer business growth to...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

Stada Acquires Fortacell To Grow In Balkans

 
• By Tom Gallen

Stada's Serbian subsidiary Hemofarm has enhanced its offering in the dietary supplements category with the acquisition of Fortacell from Goodwill Pharma.

Vision Healthcare Strikes Deals To Expand European Offering

 
• By Tom Gallen

Belgium-based Vision Healthcare has acquired Svenskt Kosttillskott in Sweden and New Care Supplements in the Netherlands.

Portfolios In Large US Food Industry Merger Cleared By FTC Include Nutritional Supplements

 
• By Malcolm Spicer

FTC decision, says Bureau of Competition director Daniel Guarnera, influenced by both companies marketing different lines in different countries, limiting the number of similar products in the same categories the combined firm would offer.

Danone Acquires Belgian Firm Marketing Gut Health Supplement in US

 
• By Tom Gallen

Danone moves into dietary supplements space with deal for The Akkermansia Company marketing patented biotic strain in US, Europe and Asia.

More from Business

Vision Healthcare Strikes Deals To Expand European Offering

 
• By Tom Gallen

Belgium-based Vision Healthcare has acquired Svenskt Kosttillskott in Sweden and New Care Supplements in the Netherlands.

Over The Counter: Seizing The GLP-1 Wellness Opportunity, With Kerry Group’s Mathieu Millette

 
• By David Ridley

HBW Insight speaks to Kerry Group's RDA director for digestive health, Mathieu Millette, about the opportunity represented by the global trend for GLP-1 agonists for consumer health.

Consumers More Often Choosing Private Label First

 
• By Malcolm Spicer

First Insight report from survey conducted in April with 1,267 US consumers notes that the Private Label Manufacturers Association recorded private label sales increasing by nearly 4% in 2024 to a record $271bn.